What is the appropriate management for a 28‑week pregnant patient with a ferritin level of 1408 ng/mL after receiving intravenous iron?

Immediately Stop IV Iron and Monitor Closely

A ferritin level of 1408 ng/mL at 28 weeks gestation after IV iron administration indicates iron overload, and no further iron supplementation should be given. This patient requires monitoring for potential complications of excess iron rather than additional treatment.

Immediate Management Steps

Discontinue All Iron Supplementation

• Stop all IV iron immediately 1
• Discontinue oral iron supplements and prenatal vitamins containing iron
• The ferritin level of 1408 ng/mL far exceeds therapeutic targets (goal ferritin in pregnancy is 50-100 ng/mL) 1

Laboratory Monitoring

Check the following within 1-2 weeks:

• Complete blood count (CBC) with hemoglobin
• Serum ferritin
• Transferrin saturation (TSAT) - calculated as serum iron divided by total iron binding capacity
• Liver function tests (to assess for iron-related hepatotoxicity)

Do not recheck iron parameters within 4 weeks of the last IV iron dose, as circulating iron interferes with assays leading to spurious results 1. However, given this markedly elevated ferritin, earlier monitoring is warranted to assess the trajectory.

Clinical Context and Reasoning

Understanding the Ferritin Elevation

Normal ferritin targets after IV iron treatment should be approximately 50 ng/mL in the absence of inflammation, with levels up to 100-175 ng/mL considered adequate response 1, 2. This patient's ferritin of 1408 ng/mL represents a 14-28 fold elevation above target, suggesting either:

• Excessive IV iron dosing
• Underlying inflammatory condition falsely elevating ferritin
• Rare iron storage disorder (though unlikely given recent IV iron administration)

Pregnancy-Specific Considerations

The third trimester (weeks 28-40) is when anemia may be less associated with adverse outcomes compared to earlier pregnancy 3. Recent evidence shows IV iron improves hemoglobin levels and reduces preterm labor and cesarean section rates 2, 4, but these benefits apply to iron-deficient patients, not those with iron overload.

Ongoing Management Algorithm

If Hemoglobin is Normal (≥11 g/dL at 28 weeks):

1. Monitor ferritin monthly until delivery
2. Expect gradual decline in ferritin over subsequent months
3. No iron supplementation needed
4. Reassess postpartum if significant blood loss occurs

If Hemoglobin is Low Despite High Ferritin:

This suggests functional iron deficiency or another cause of anemia:

1. Check TSAT - if <20%, indicates functional iron deficiency despite high ferritin 1
2. Consider reticulocyte hemoglobin content (CHr) or equivalent (RET-He) if available 1
3. Evaluate for other causes: B12/folate deficiency, hemolysis, chronic disease
4. Do NOT give additional iron unless TSAT confirms true functional deficiency with ongoing losses

Postpartum Considerations

• If postpartum hemorrhage occurs, reassess iron status 4-6 weeks after delivery
• The patient described in 5 with ferroportin disease and ferritin >5000 ng/mL successfully treated postpartum anemia with only 2 weeks of oral iron, demonstrating that high ferritin doesn't preclude appropriate response to blood loss

Critical Pitfalls to Avoid

Do not reflexively give more iron based on gestational age or routine protocols. The markedly elevated ferritin indicates the patient has received adequate—likely excessive—iron stores.

Do not ignore the possibility of inflammation. Ferritin is an acute phase reactant. If the patient has infection, inflammatory bowel disease, or other inflammatory conditions, the ferritin may be falsely elevated 1. Check TSAT to clarify true iron status.

Do not delay evaluation if symptoms develop. Iron overload can cause hepatotoxicity, though this is rare with therapeutic IV iron dosing. Monitor for right upper quadrant pain, elevated liver enzymes, or other concerning symptoms.

Evidence Quality Note

While recent high-quality evidence supports IV iron for treating iron deficiency anemia in pregnancy 2, 4, these studies enrolled patients with documented deficiency (ferritin <30 ng/mL, hemoglobin <11 g/dL). The expert consensus guidelines 1 provide the most relevant framework for managing post-IV iron monitoring and interpreting elevated ferritin levels, though they don't specifically address pregnancy. The USPSTF guidelines 3 acknowledge limitations in ferritin interpretation during pregnancy's physiologic changes but don't provide specific thresholds for iron overload.